ArticleHeliyon2021

Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (alpha strain) targeting the spike protein: molecular docking and simulation studies.

Monu Pande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.